nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—GABRB3—GABA A receptor activation—GABRA4—nicotine dependence	0.0327	0.0679	CbGpPWpGaD
Lorazepam—GABRG2—GABA A receptor activation—GABRA4—nicotine dependence	0.0321	0.0667	CbGpPWpGaD
Lorazepam—GABRA1—GABA A receptor activation—GABRA4—nicotine dependence	0.0281	0.0583	CbGpPWpGaD
Lorazepam—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0252	0.0518	CcSEcCtD
Lorazepam—Balance disorder—Varenicline—nicotine dependence	0.0239	0.0491	CcSEcCtD
Lorazepam—Hostility—Varenicline—nicotine dependence	0.0236	0.0485	CcSEcCtD
Lorazepam—Sleep disturbance—Varenicline—nicotine dependence	0.0233	0.0479	CcSEcCtD
Lorazepam—GABRB3—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.02	0.0416	CbGpPWpGaD
Lorazepam—GABRG2—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0197	0.0408	CbGpPWpGaD
Lorazepam—Suicidal ideation—Varenicline—nicotine dependence	0.0186	0.0383	CcSEcCtD
Lorazepam—Mania—Varenicline—nicotine dependence	0.0179	0.0369	CcSEcCtD
Lorazepam—Extrapyramidal disorder—Varenicline—nicotine dependence	0.0173	0.0357	CcSEcCtD
Lorazepam—GABRA1—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.0172	0.0357	CbGpPWpGaD
Lorazepam—Aggression—Varenicline—nicotine dependence	0.0149	0.0306	CcSEcCtD
Lorazepam—Thinking abnormal—Varenicline—nicotine dependence	0.0143	0.0294	CcSEcCtD
Lorazepam—Leukocytosis—Varenicline—nicotine dependence	0.0139	0.0286	CcSEcCtD
Lorazepam—Dysarthria—Varenicline—nicotine dependence	0.0138	0.0284	CcSEcCtD
Lorazepam—Salivary hypersecretion—Varenicline—nicotine dependence	0.0127	0.0261	CcSEcCtD
Lorazepam—Mental disability—Varenicline—nicotine dependence	0.0113	0.0233	CcSEcCtD
Lorazepam—Euphoric mood—Varenicline—nicotine dependence	0.0112	0.0231	CcSEcCtD
Lorazepam—Sleep disorder—Varenicline—nicotine dependence	0.0109	0.0225	CcSEcCtD
Lorazepam—GABRB3—GABA receptor activation—GABRA4—nicotine dependence	0.0106	0.0221	CbGpPWpGaD
Lorazepam—Disorientation—Varenicline—nicotine dependence	0.0106	0.0218	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—CYP2A7—nicotine dependence	0.0105	0.0218	CbGpPWpGaD
Lorazepam—GABRG2—GABA receptor activation—GABRA4—nicotine dependence	0.0104	0.0217	CbGpPWpGaD
Lorazepam—Amnesia—Varenicline—nicotine dependence	0.0101	0.0208	CcSEcCtD
Lorazepam—Visual disturbance—Varenicline—nicotine dependence	0.01	0.0206	CcSEcCtD
Lorazepam—Lethargy—Varenicline—nicotine dependence	0.00967	0.0199	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00947	0.0195	CcSEcCtD
Lorazepam—Osteoarthritis—Varenicline—nicotine dependence	0.00947	0.0195	CcSEcCtD
Lorazepam—Psychotic disorder—Varenicline—nicotine dependence	0.00925	0.019	CcSEcCtD
Lorazepam—GABRA1—GABA receptor activation—GABRA4—nicotine dependence	0.00912	0.0189	CbGpPWpGaD
Lorazepam—Irritability—Varenicline—nicotine dependence	0.00904	0.0186	CcSEcCtD
Lorazepam—Liver function test abnormal—Varenicline—nicotine dependence	0.00875	0.018	CcSEcCtD
Lorazepam—Erectile dysfunction—Varenicline—nicotine dependence	0.00754	0.0155	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00713	0.0148	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.007	0.0145	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00676	0.014	CbGpPWpGaD
Lorazepam—Bradycardia—Varenicline—nicotine dependence	0.00667	0.0137	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00664	0.0138	CbGpPWpGaD
Lorazepam—Hallucination—Varenicline—nicotine dependence	0.00652	0.0134	CcSEcCtD
Lorazepam—Visual impairment—Varenicline—nicotine dependence	0.00632	0.013	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—GABRA4—nicotine dependence	0.0062	0.0129	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00612	0.0127	CbGpPWpGaD
Lorazepam—GABRG2—Orphan transporters—GABRA4—nicotine dependence	0.00609	0.0126	CbGpPWpGaD
Lorazepam—Chills—Varenicline—nicotine dependence	0.00588	0.0121	CcSEcCtD
Lorazepam—Arrhythmia—Varenicline—nicotine dependence	0.00585	0.0121	CcSEcCtD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.0058	0.012	CbGpPWpGaD
Lorazepam—Erythema—Varenicline—nicotine dependence	0.00571	0.0117	CcSEcCtD
Lorazepam—Bromazepam—GABRA4—nicotine dependence	0.00545	0.167	CrCbGaD
Lorazepam—Vision blurred—Varenicline—nicotine dependence	0.00538	0.0111	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00536	0.0111	CbGpPWpGaD
Lorazepam—Tremor—Varenicline—nicotine dependence	0.00535	0.011	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—GABRA4—nicotine dependence	0.00532	0.011	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00526	0.0109	CbGpPWpGaD
Lorazepam—Agitation—Varenicline—nicotine dependence	0.00524	0.0108	CcSEcCtD
Lorazepam—Vertigo—Varenicline—nicotine dependence	0.00513	0.0106	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00508	0.0105	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00499	0.0104	CbGpPWpGaD
Lorazepam—Convulsion—Varenicline—nicotine dependence	0.00494	0.0102	CcSEcCtD
Lorazepam—Hypertension—Varenicline—nicotine dependence	0.00493	0.0101	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00489	0.0101	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.0048	0.00996	CbGpPWpGaD
Lorazepam—Dry mouth—Varenicline—nicotine dependence	0.00475	0.00978	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00468	0.00972	CbGpPWpGaD
Lorazepam—Infection—Varenicline—nicotine dependence	0.00463	0.00952	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0046	0.00955	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.0046	0.00955	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Varenicline—nicotine dependence	0.00456	0.00939	CcSEcCtD
Lorazepam—Tachycardia—Varenicline—nicotine dependence	0.00454	0.00936	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00436	0.00905	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00435	0.00904	CbGpPWpGaD
Lorazepam—Hypotension—Varenicline—nicotine dependence	0.00435	0.00896	CcSEcCtD
Lorazepam—GABRB3—Ion channel transport—GABRA4—nicotine dependence	0.00435	0.00903	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00428	0.00888	CbGpPWpGaD
Lorazepam—GABRG2—Ion channel transport—GABRA4—nicotine dependence	0.00427	0.00886	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00419	0.00871	CbGpPWpGaD
Lorazepam—Somnolence—Varenicline—nicotine dependence	0.00414	0.00852	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—CHRNB3—nicotine dependence	0.00411	0.00852	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNB3—nicotine dependence	0.00403	0.00837	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00402	0.00835	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00402	0.00828	CcSEcCtD
Lorazepam—Fatigue—Varenicline—nicotine dependence	0.00401	0.00826	CcSEcCtD
Lorazepam—Constipation—Varenicline—nicotine dependence	0.00398	0.0082	CcSEcCtD
Lorazepam—Pain—Varenicline—nicotine dependence	0.00398	0.0082	CcSEcCtD
Lorazepam—GABRB3—Neuronal System—CHRNA6—nicotine dependence	0.00389	0.00808	CbGpPWpGaD
Lorazepam—Feeling abnormal—Varenicline—nicotine dependence	0.00384	0.0079	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—CHRNA6—nicotine dependence	0.00382	0.00794	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00374	0.00776	CbGpPWpGaD
Lorazepam—GABRA1—Ion channel transport—GABRA4—nicotine dependence	0.00373	0.00775	CbGpPWpGaD
Lorazepam—Halazepam—GABRA4—nicotine dependence	0.00373	0.114	CrCbGaD
Lorazepam—Nitrazepam—GABRA4—nicotine dependence	0.0037	0.114	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00369	0.00765	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00367	0.00763	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00361	0.00749	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00355	0.00737	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNB3—nicotine dependence	0.00352	0.00732	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00352	0.00731	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00349	0.00724	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00346	0.00718	CbGpPWpGaD
Lorazepam—Hypersensitivity—Varenicline—nicotine dependence	0.00343	0.00706	CcSEcCtD
Lorazepam—GABRA1—Neuronal System—CHRNA6—nicotine dependence	0.00334	0.00694	CbGpPWpGaD
Lorazepam—Asthenia—Varenicline—nicotine dependence	0.00334	0.00688	CcSEcCtD
Lorazepam—Flurazepam—GABRA4—nicotine dependence	0.00329	0.101	CrCbGaD
Lorazepam—Triazolam—GABRA4—nicotine dependence	0.00329	0.101	CrCbGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00327	0.0068	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00321	0.00667	CbGpPWpGaD
Lorazepam—Oxazepam—GABRA4—nicotine dependence	0.00319	0.0978	CrCbGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00315	0.00654	CbGpPWpGaD
Lorazepam—Temazepam—GABRA4—nicotine dependence	0.00315	0.0965	CrCbGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00313	0.00649	CbGpPWpGaD
Lorazepam—Dizziness—Varenicline—nicotine dependence	0.00308	0.00634	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00307	0.00637	CbGpPWpGaD
Lorazepam—Midazolam—GABRA4—nicotine dependence	0.00305	0.0936	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00305	0.00633	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00302	0.00627	CbGpPWpGaD
Lorazepam—Vomiting—Varenicline—nicotine dependence	0.00296	0.0061	CcSEcCtD
Lorazepam—Rash—Varenicline—nicotine dependence	0.00294	0.00604	CcSEcCtD
Lorazepam—Dermatitis—Varenicline—nicotine dependence	0.00293	0.00604	CcSEcCtD
Lorazepam—Headache—Varenicline—nicotine dependence	0.00292	0.00601	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00284	0.00589	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GABRA4—nicotine dependence	0.00281	0.00584	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00281	0.00583	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00279	0.00579	CbGpPWpGaD
Lorazepam—Nausea—Varenicline—nicotine dependence	0.00277	0.00569	CcSEcCtD
Lorazepam—GABRG2—Neuronal System—GABRA4—nicotine dependence	0.00276	0.00574	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNB4—nicotine dependence	0.0027	0.0056	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00268	0.00557	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00267	0.00554	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNB4—nicotine dependence	0.00265	0.0055	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00262	0.00544	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNA5—nicotine dependence	0.00251	0.00521	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNA5—nicotine dependence	0.00246	0.00511	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00246	0.00511	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00244	0.00506	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GABRA4—nicotine dependence	0.00242	0.00501	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00235	0.00488	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNB4—nicotine dependence	0.00232	0.00481	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00231	0.00479	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00229	0.00476	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00223	0.00464	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNA5—nicotine dependence	0.00215	0.00447	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00213	0.00443	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00209	0.00435	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNA3—nicotine dependence	0.00204	0.00425	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00202	0.00419	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNA3—nicotine dependence	0.00201	0.00417	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00183	0.0038	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNB2—nicotine dependence	0.0018	0.00374	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2A7—nicotine dependence	0.0018	0.00373	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNB2—nicotine dependence	0.00177	0.00367	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNA3—nicotine dependence	0.00176	0.00364	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNA4—nicotine dependence	0.00163	0.00339	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNA4—nicotine dependence	0.00161	0.00333	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNB2—nicotine dependence	0.00155	0.00321	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00151	0.00314	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00149	0.00308	CbGpPWpGaD
Lorazepam—Amoxapine—DRD2—nicotine dependence	0.00148	0.0454	CrCbGaD
Lorazepam—GABRA1—Neuronal System—CHRNA4—nicotine dependence	0.0014	0.00291	CbGpPWpGaD
Lorazepam—Chlorprothixene—DRD2—nicotine dependence	0.00133	0.0407	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0013	0.0027	CbGpPWpGaD
Lorazepam—Clozapine—DRD2—nicotine dependence	0.000971	0.0298	CrCbGaD
